News
The lack of details about which countries are involved and which companies will be impacted as a result of the new trade deal ...
WeightWatchers announces Dr. Kim Boyd as its new chief medical officer and unveils a program to support women through ...
WeightWatchers will announce on Tuesday Dr. Kim Boyd as its chief medical officer, and plans for a new program to help women manage the transition into menopause and beyond, part of its growth ...
Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Novo Nordisk A/S (NYSE:NVO) ranks among the best set-it-and-forget-it stocks to buy. Novo Nordisk A/S (NYSE:NVO) announced on ...
Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.
6d
Stocktwits on MSNWegovy for $299? Retail Buzz Erupts As WeightWatchers, Novo Nordisk Expand Obesity Drug PushRetail chatter around WW International surged Tuesday after the company’s expanded collaboration with Novo Nordisk officially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results